STOCK TITAN

Cannabis Strateg Vntre (NUGS) Stock Price, News & Analysis

NUGS OTC
Published by Stock Titan Data refreshed

Why is NUGS Stock Up Today?

31.58% today

Cannabis Strategic Ventures (OTC: NUGS) signed a binding letter of intent to combine with Scopien Technologies, an Ontario AI platform company. Scopien would acquire voting control through a transfer of NUGS’s Series B Super Voting Preferred Stock and contribute its operating business. The parties intend to complete the change of control by November 30, 2026.

NUGS terminated its non-binding Adport acquisition letter of intent; no definitive agreements were signed. NUGS plans audits and an SEC registration filing within six months after the control change, targeting fully reporting status and a Nasdaq or NYSE listing. Reported liabilities were approximately $491,000 at September 30, 2026, versus more than $14.6 million in legacy liabilities when a custodian was appointed in July 2025.

AI-generated explanation by Rhea-AI. How Rhea-AI works. Not financial advice.

Price Move History

Daily moves over 5%
51 168 sessions, December 30, 2025 to November 2, 2026
Largest daily move
+1520% close of August 27, 2026
1-month change
-46.5% closing prices, October 2, 2026 to November 2, 2026

Company Description

Cannabis Strateg Vntre (OTC: NUGS) is classified in the shell companies industry within the Financial Services sector and carries a market capitalization of $2.0M.

NUGS has gained 533.3% so far this year. The last closing price was $0.0038.

This page collects what Stock Titan holds for NUGS, including price data, latest news, and upcoming events.

Stock Performance

$0.0050
+31.58%
+0.0012
Last updated: November 3, 2026 at 09:56
+533.3%
Performance this year

Cannabis Strateg Vntre (NUGS) closed at $0.0038 on November 2, 2026. So far this year, the price has gained 533.3%.

See what a $1,000 investment in NUGS would be worth today

Average down calculator for NUGS

NUGS Metrics & Rankings

Price returns through November 2, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Cannabis Strateg Vntre has 9 recent news articles, with the latest published today. Of the recent coverage, 7 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all NUGS news →

SEC Filings

No SEC filings available for NUGS.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Operating Cash Flow

Upcoming Events

NOV
30
November 30, 2026 Corporate

Change of control

Binding LOI to combine with Scopien; Scopien to acquire voting control via Series B transfer, target close Nov 30, 2026.
DEC
2026
December 2026 Financial

SEC registration filing

Company plans audits and an SEC registration filing within six months after the control change; targets Nasdaq/NYSE listing.

Cannabis Strateg Vntre has 2 upcoming scheduled events. The next event, "Change of control", is scheduled for November 30, 2026 (in 27 days). 1 of them is a financing or capital event, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the NUGS stock price.

NUGS Company Profile & Sector Positioning

Cannabis Strateg Vntre (NUGS) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC.

Investors comparing NUGS often look at related companies in the same sector, including Alternaturals Inc (ANAS), Cycclone Inc (CYCL), SETO Holdings Inc (SETO), Ranger Gold Corp (RNGC), and Zhuding Inter Ltd CL (A) (ZHUD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NUGS's relative position within its industry.

Frequently Asked Questions

The current stock price of Cannabis Strateg Vntre (NUGS) is $0.0050 as of November 3, 2026.

The market cap of Cannabis Strateg Vntre (NUGS) is approximately $2.0M. Learn more about what market capitalization means .